News

High-Dose PDT May Offer "Cure" for Acne


 

EXPERT ANALYSIS FROM SDEF HAWAII DERMATOLOGY SEMINAR

A blinded, split-face comparative study of high-dose red light PDT testing various parameters is underway at Massachusetts General Hospital and should be completed in about 6 months.

Dr. Anderson has been awarded more than 60 patents and is responsible for numerous seminal advances in laser medicine. Many top laser experts have trained under him, a process they call "getting Roxified," in which they acquire a spirit of open-minded inquiry.

Dr. Anderson declared having no relevant financial interests. SDEF and this news organization are owned by Elsevier.

Pages

Recommended Reading

Custom Allergen Testing Boosts Occupational Dermatitis Diagnoses
MDedge Internal Medicine
ACDS Launches Contact Allergen Management Program (CAMP)
MDedge Internal Medicine
Predictors of Sézary Syndrome Response to Multimodality Therapy
MDedge Internal Medicine
Contact Dermatitis Found More Common in Children With Atopy
MDedge Internal Medicine
Serum Test Could Define Need for SLN Biopsy in Melanoma
MDedge Internal Medicine
Two Sclerotherapy Methods Yield Similar 6-Month Outcomes
MDedge Internal Medicine
Foam Sclerotherapy Appears as Effective as Surgery for Varicose Veins
MDedge Internal Medicine
Capecitabine May Protect Against Skin Cancers After Transplant
MDedge Internal Medicine
FDA Okay Expected Soon for Melanoma Drug Ipilimumab
MDedge Internal Medicine
Predictors Help Differentiate Cellulitis From Its Imitators
MDedge Internal Medicine